Erratum to: Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).
Oki E, Emi Y, Miyamoto Y, Kabashima A, Higashi H, Ogata Y, Ikebe M, Saeki H, Tokunaga S, Shirabe K, Beppu T, Uchida S, Takatsuki M, Sakoda M, Eguchi S, Akagi Y, Kakeji Y, Baba H, Natsugoe S, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).
Oki E, et al. Among authors: takatsuki m.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1617. doi: 10.1245/s10434-015-4864-x.
Ann Surg Oncol. 2015.
PMID: 26391505
No abstract available.